Physician profile
Dennis Bonner
NPI 1528029311
$2,732.67
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,013 · 2020: $720.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $749.38 | 2019 | |
| Novartis Pharmaceuticals Corporation | $410.57 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $251.12 | 2019-2020 | |
| Biotronik INC. | $245.37 | 2019-2020 | |
| Pfizer INC. | $157.50 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $154.53 | 2019-2020 | |
| Astellas Pharma US INC | $123.40 | 2019-2020 | |
| Amgen INC. | $105.05 | 2019-2020 | |
| Lundbeck LLC | $102.86 | 2019 | |
| Abbott Laboratories | $92.94 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $85.28 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $66.15 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $59.40 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.55 | 2019 | |
| Siemens Medical Solutions USA, INC. | $20.78 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $19.95 | 2019 | |
| Irhythm Technologies, INC. | $15.73 | 2019 | |
| Portola Pharmaceuticals, LLC | $14.37 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.05 | 2020 | |
| Medtronic Vascular, INC. | $11.69 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Bonner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.